NDC 0641-6022-01 - Famotidine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6022
- Requested NDC
- 0641-6022-01
- Package NDCs from labels
- 0641-6022-01, 0641-6022-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Famotidine Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Famotidine - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-08 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6022-01 | Famotidine | 2 mL in 1 VIAL | INJECTION | 2 | 9 | |
| 0641-6022-25 | Famotidine | 25 in 1 CARTON | INJECTION | 25 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6022-01 | ML - Milliliter | 0641-6022 | 14529626-4b70-42c6-a890-9b69073ec03a | 1 | 2013-02-13 |
| 0641-6022-25 | ML - Milliliter | 0641-6022 | 4387b354-0e9e-4478-9b06-72f87bf78c58 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| ASPARTIC ACID | INACTIVE INGREDIENT | 30KYC7MIAI | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | Henry Schein, Inc. | 88403fcf-a276-42c0-88b6-bd84a720b564 | 2025-05-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Ibuprofen and Famotidine | IBUPROFEN AND FAMOTIDINE | Zydus Lifesciences Limited | 24204938-0989-42ad-8ad8-89979e62d700 | 2025-05-28 | 5QZO15J2Z8 | |
| Ibuprofen and Famotidine | IBUPROFEN AND FAMOTIDINE | Viona Pharmaceuticals Inc | 66524c84-35bc-4e7f-897a-f63fa4bca432 | 2025-05-28 | Boxed warning, Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Precision Dose, Inc. | de42b6c4-c44b-4ec1-b505-fc5266452d57 | 2025-05-27 | Warnings | 5QZO15J2Z8 |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| Eyesaline Emergency Eyewash | STERILE EYESALINE EYEWASH | Honeywell Safety Products USA, Inc. | 2d567518-4c54-7448-e063-6294a90a3e64 | 2025-05-14 | Warnings | 059QF0KO0R |
| Zantac 360 | FAMOTIDINE | Chattem, Inc. | 89f60eb1-359b-40e8-ae8b-65aec9cd5b1f | 2025-05-09 | Warnings | 5QZO15J2Z8 |
| Famotidine 20 mg | FAMOTIDINE 20 MG | MARKSANS PHARMA LIMITED | 5a66206b-35b1-4d86-8574-a1e45cb0772f | 2025-05-06 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Lannett Company, Inc. | 7e0da8be-b001-400e-99d1-37f335b1d7b3 | 2025-05-02 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Magno-Humphries, Inc. | f5d5b40e-82e5-4284-9f3f-d2c0e88f0ab9 | 2025-05-02 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Magno-Humphries, Inc. | ed32f72a-e220-440f-a74f-b754a313f004 | 2025-05-02 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | LEADER/ CARDINAL HEALTH 110, INC. | 78b168f1-846d-4e88-a8ee-845c41c9dcbe | 2025-04-23 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Bryant Ranch Prepack | 11ce2a78-76ce-44df-afe3-57493498e596 | 2025-04-23 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Better Living Brands, LLC | f6f0230c-44fb-6c36-e053-6394a90ac43e | 2025-04-23 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Fred's, Inc. | 81b105a1-01fe-51d7-e053-2991aa0a71bc | 2025-04-23 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | CVS Pharmacy, Inc. | c4e35c7e-5c2f-4252-e053-2a95a90a8268 | 2025-04-22 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | CVS Pharmacy, Inc. | 479a1437-a212-49d9-b272-758c0e5b7203 | 2025-04-22 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Best Choice | fadbd056-6510-f864-e053-6294a90aa67b | 2025-04-22 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Aurohealth LLC | f2b911c7-ce24-4d3d-8fb6-c34980191f40 | 2025-04-22 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Aurohealth LLC | 6d0d8839-0680-45f6-96db-2d8edc9d4682 | 2025-04-22 | Warnings | 5QZO15J2Z8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.